Shanghai Junshi Biosciences competitors and similar companiesClear all

Shanghai Junshi Biosciences's competitors and similar companies include ZAI Lab, SK Biopharmaceuticals, IDEAYA Biosciences and Puma Biotechnology.
Shanghai Junshi Biosciences
Shanghai Junshi Biosciences
Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
ZAI Lab
ZAI Lab
Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases.
SK Biopharmaceuticals
SK Biopharmaceuticals
SK Biopharmaceuticals is a company that specializes in drug development.
IDEAYA Biosciences
IDEAYA Biosciences
IDEAYA Biosciences (IDEAYA) is a developer of molecular therapies.
Puma Biotechnology
Puma Biotechnology
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
Founding Date
Founding Date
2012
Founding Date
2014
Founding Date
1993
Founding Date
2015
Founding Date
2010
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
HQ
Locations
Shanghai, CN HQ
Beijing, CN
Suzhou, CN
Hong Kong, HK
Taipei, TW
Cambridge, US
Menlo Park, US
Locations
HQ
Locations
South San Francisco, US HQ
San Diego, US
Locations
Los Angeles, US HQ
Employees
Employees
1,875525% increase
Employees
1,951
Employees
149
Employees
56
Employees
27214% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
3.8 b
Valuation ($)
N/A
Valuation ($)
465.8 m
Valuation ($)
96.1 m
Alexa Website Rank
Alexa Website Rank
329519
Alexa Website Rank
89595
Alexa Website Rank
126900
Alexa Website Rank
220330
Alexa Website Rank
413496
Employee Rating
Employee Rating
N/A
Employee Rating
3.9
Employee Rating
3.6
Employee Rating
3
Employee Rating
3.2

Financial

Revenue (est.)
Revenue (est.)
¥3.8b (FY, 2021)
Revenue (est.)
$144.3m (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
$27.9m (FY, 2021)
Revenue (est.)
$253.2m (FY, 2021)
Cost of goods
Cost of goods
¥1.2b (FY, 2021)
Cost of goods
$44.4m (FY, 2021)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$63.7m (FY, 2021)
Gross profit
Gross profit
¥2.8b (FY, 2021)
Gross profit
$99.9m (FY, 2021)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Net income
Net income
(¥730.5m) (FY, 2021)
Net income
($703.4m) (FY, 2021)
Net income
N/A
Net income
($49.8m) (FY, 2021)
Net income
($29.1m) (FY, 2021)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 985m
Total funding raised
N/A
Total funding raised
$ 140m
Total funding raised
$ 172m
For sources of this data, please see the company profile

View company profiles

ZAI Lab
HQ
Shanghai, CN
Employees
1,951

Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases.

View company
SK Biopharmaceuticals
HQ

SK Biopharmaceuticals is a company that specializes in drug development.

View company
IDEAYA Biosciences
HQ
South San Francisco, US
Employees
56

IDEAYA Biosciences (IDEAYA) is a developer of molecular therapies.

View company
Puma Biotechnology
HQ
Los Angeles, US
Employees
272↓ 14% decrease

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.

View company